咔唑类

描述:

含有三环体系的化合物,其中吡咯环两侧分别与苯环相连。

产品列表

视图 列表 网格

显示第481至492个,产品总数492个

设置降序方向
  1. 2,4,6-三(9H-咔唑-9-基)-1,3,5-三嗪
    CAS: 134984-37-5 化合物 CID: 23399531 分子式: C39H24N6 分子量: 576.66
    有现货 货号: T121306
    查看产品
    价格与包装
    技术标识符
    IUPAC名称
    9-[4,6-di(carbazol-9-yl)-1,3,5-triazin-2-yl]carbazole
    SMILES
    C1=CC=C2C(=C1)C3=CC=CC=C3N2C4=NC(=NC(=N4)N5C6=CC=CC=C6C7=CC=CC=C75)N8C9=CC=CC=C9C1=CC=CC=C18
    InChIKey
    NPLMKKHOVKWGEO-UHFFFAOYSA-N
    InChI
    1S/C39H24N6/c1-7-19-31-25(13-1)26-14-2-8-20-32(26)43(31)37-40-38(44-33-21-9-3-15-27(33)28-16-4-10-22-34(28)44)42-39(41-37)45-35-23-11-5-17-29(35)30-18-6-12-24-36(30)45/h1-24H
  2. Stauprimide,抑制剂
    CAS: 154589-96-5 化合物 CID: 46245328 分子式: C35H28N4O5 分子量: 584.62
    有现货 货号: S139814
    查看产品
    价格与包装
    技术标识符
    IUPAC名称
    N-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16,18-dioxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methylbenzamide
    SMILES
    CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)C(=O)NC6=O)N(C)C(=O)C9=CC=CC=C9)OC
    InChIKey
    MQCCJEYZKWZQHU-MPRCCEKMSA-N
    InChI
    1S/C35H28N4O5/c1-35-31(43-3)23(37(2)34(42)18-11-5-4-6-12-18)17-24(44-35)38-21-15-9-7-13-19(21)25-27-28(33(41)36-32(27)40)26-20-14-8-10-16-22(20)39(35)30(26)29(25)38/h4-16,23-24,31H,17H2,1-3H3,(H,36,40显示更多
  3. 星形孢菌素
    CAS: 62996-74-1 EC号: 613-127-7 化合物 CID: 44259 分子式: C28H26N4O3 分子量: 466.53
    Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。 ≥98%
    有现货 货号: S102392
    查看产品
    价格与包装
    技术标识符
    IUPAC名称
    (2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one
    SMILES
    CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)NC)OC
    InChIKey
    HKSZLNNOFSGOKW-FYTWVXJKSA-N
    InChI
    1S/C28H26N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h4-11,17,20,26,29H,12-13H2,1-3H3,(H,30,33)/t17-,20-,26-,28+/m1/s1
    关联靶标
    Cyclin-dependent kinase 1, Peripheral plasma membrane protein CASK, Tyrosine-protein kinase CSK, Serine/threonine-protein kinase/endoribonuclease IRE2, Serine/threonine-protein kinase/endoribonuclease IRE1, Ephrin type-A receptor 4, Ephrin type-B receptor 1, Receptor tyrosine-protein kinase erbB-4, Ephrin type-A receptor 5, Receptor tyrosine-protein kinase erbB-2, Dual specificity tyrosine-phosphorylation-regulated kinase 1B, Dual specificity tyrosine-phosphorylation-regulated kinase 3, eIF-2-alpha kinase GCN2, Myotonin-protein kinase, Dual specificity tyrosine-phosphorylation-regulated kinase 1A, Discoidin domain-containing receptor 2, Dual serine/threonine and tyrosine protein kinase, Epidermal growth factor receptor, Focal adhesion kinase 1, Ephrin type-A receptor 3, Macrophage colony-stimulating factor 1 receptor, Casein kinase II subunit alpha', Death-associated protein kinase 3, Cyclin-dependent kinase 16, Cyclin-dependent kinase 4, Serine/threonine-protein kinase DCLK3, Cyclin-dependent kinase 2, Death-associated protein kinase 2, Epithelial discoidin domain-containing receptor 1, Death-associated protein kinase 1, Proto-oncogene tyrosine-protein kinase receptor Ret, Retinoblastoma-associated protein, Protein odd-skipped-related 1, Serine/threonine-protein kinase PAK 5, cAMP-dependent protein kinase catalytic subunit PRKX, Rhodopsin kinase, Serine/threonine-protein kinase Sgk2, SRSF protein kinase 1, Serine/threonine-protein kinase Sgk1, Serine/threonine-protein kinase Sgk3, Proto-oncogene tyrosine-protein kinase Src, Rho-associated protein kinase 2, Serine/threonine-protein kinase SBK1, Lysine--tRNA ligase, Uncharacterized serine/threonine-protein kinase SBK3, Rho-associated protein kinase 1, Proto-oncogene tyrosine-protein kinase ROS, Serine/threonine-protein kinase 17A, Serine/threonine-protein kinase 38-like, Serine/threonine-protein kinase 25, Serine/threonine-protein kinase 26, Serine/threonine-protein kinase 10, Serine/threonine-protein kinase 33, STE20/SPS1-related proline-alanine-rich protein kinase, Serine/threonine-protein kinase 3, Serine/threonine-protein kinase 17B, Serine/threonine-protein kinase 32B, Serine/threonine-protein kinase 24, Serine/threonine-protein kinase 38, Serine/threonine-protein kinase 4, Tyrosine-protein kinase TXK, Vascular endothelial growth factor receptor 3, Tyrosine-protein kinase Yes, Tyrosine-protein kinase receptor TYRO3, Non-receptor tyrosine-protein kinase TYK2, Interleukin-1 receptor-associated kinase 4, Serine/threonine-protein kinase ICK, Interleukin-1 receptor-associated kinase 1, Inhibitor of nuclear factor kappa-B kinase subunit epsilon, Inhibitor of nuclear factor kappa-B kinase subunit alpha, Inhibitor of nuclear factor kappa-B kinase subunit beta, Tyrosine-protein kinase FRK, Tyrosine-protein kinase Fyn, Ephrin type-A receptor 6, Serine/threonine-protein kinase haspin, Calcium/calmodulin-dependent protein kinase kinase 2, Tyrosine-protein kinase Fer, Receptor-type tyrosine-protein kinase FLT3, Cyclin-G-associated kinase, Fibroblast growth factor receptor 1, Fibroblast growth factor receptor 2, Tyrosine-protein kinase Fes/Fps, Protein-tyrosine kinase 2-beta, Fibroblast growth factor receptor 3, Tyrosine-protein kinase Fgr, Glucokinase, Homeodomain-interacting protein kinase 1, Interleukin-1 receptor-associated kinase 3, Calcium/calmodulin-dependent protein kinase type 1B, Calcium/calmodulin-dependent protein kinase type 1D, Calcium/calmodulin-dependent protein kinase type 1G, Insulin-like growth factor 1 receptor, Maternal embryonic leucine zipper kinase, Tyrosine-protein kinase ITK/TSK, Tyrosine-protein kinase JAK3, cAMP-dependent protein kinase catalytic subunit beta, cAMP-dependent protein kinase catalytic subunit gamma, Calcium/calmodulin-dependent protein kinase type II subunit beta, Tyrosine-protein kinase Mer, Testis-specific serine/threonine-protein kinase 1, Thioredoxin reductase 1, cytoplasmic, Serine/threonine-protein kinase tousled-like 2, SNF-related serine/threonine-protein kinase, Non-receptor tyrosine-protein kinase TNK1, Serine/threonine-protein kinase SIK1, Serine/threonine-protein kinase SIK2, TRAF2 and NCK-interacting protein kinase, Serine/threonine-protein kinase TBK1, Serine/threonine-protein kinase TAO1, Tyrosine-protein kinase Tec, Serine/threonine-protein kinase TAO2, Serine/threonine-protein kinase TAO3, Serine/threonine-protein kinase tousled-like 1, Serine/threonine-protein kinase SIK3, STE20-like serine/threonine-protein kinase, Testis-specific serine/threonine-protein kinase 2, Testis-specific serine/threonine-protein kinase 3, Serine/threonine-protein kinase PLK4, Serine/threonine-protein kinase pim-1, Serine/threonine-protein kinase N3, Serine/threonine-protein kinase N1, Platelet-derived growth factor receptor alpha, Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform, Serine/threonine-protein kinase pim-2, Serine/threonine-protein kinase pim-3, Phosphorylase b kinase gamma catalytic chain, liver/testis isoform, Platelet-derived growth factor receptor beta, [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial, Inactive tyrosine-protein kinase PEAK1, Serine/threonine-protein kinase N2, cGMP-dependent protein kinase 1, Ribosomal protein S6 kinase beta-1, Misshapen-like kinase 1, MAP kinase-interacting serine/threonine-protein kinase 2, Serine/threonine-protein kinase LATS1, cGMP-dependent protein kinase 2, Protein kinase C delta type, Ribosomal protein S6 kinase alpha-1, Ribosomal protein S6 kinase alpha-2, Tyrosine-protein kinase SYK, Protein kinase C beta type, Serine/threonine-protein kinase D2, Protein kinase C epsilon type, Ribosomal protein S6 kinase alpha-6, Mitogen-activated protein kinase 15, Serine/threonine-protein kinase LATS2, Protein kinase C eta type, Ribosomal protein S6 kinase alpha-5, Serine/threonine-protein kinase D1, Protein kinase C iota type, Mitogen-activated protein kinase kinase kinase 15, Serine/threonine-protein kinase MARK2, Dual specificity mitogen-activated protein kinase kinase 2, Dual specificity mitogen-activated protein kinase kinase 3, Mitogen-activated protein kinase kinase kinase kinase 2, Serine/threonine-protein kinase Nek8, LIM domain kinase 1, Mitogen-activated protein kinase kinase kinase 19, Mitogen-activated protein kinase kinase kinase 10, Tyrosine-protein kinase Lck, Leukocyte tyrosine kinase receptor, Mitogen-activated protein kinase kinase kinase 12, Mitogen-activated protein kinase kinase kinase kinase 1, MAP/microtubule affinity-regulating kinase 3, MAP/microtubule affinity-regulating kinase 4, Mitogen-activated protein kinase kinase kinase kinase 3, Leucine-rich repeat serine/threonine-protein kinase 2, Serine/threonine-protein kinase Nek1, Mitogen-activated protein kinase kinase kinase kinase 4, Mitogen-activated protein kinase kinase kinase kinase 5, Mitogen-activated protein kinase kinase kinase 11, Mitogen-activated protein kinase kinase kinase 2, Mitogen-activated protein kinase kinase kinase 3, Serine/threonine-protein kinase MAK, Dual specificity mitogen-activated protein kinase kinase 6, Tyrosine-protein kinase JAK1, Serine/threonine-protein kinase MRCK alpha, Tyrosine-protein kinase Lyn, Mitogen-activated protein kinase kinase kinase 5, Dual specificity mitogen-activated protein kinase kinase 4, Cytochrome P450 11B2, mitochondrial, BMP-2-inducible protein kinase, Serine/threonine-protein kinase B-raf, Serine/threonine-protein kinase BRSK2, Tyrosine-protein kinase BTK, Serine/threonine-protein kinase BRSK1, Cytoplasmic tyrosine-protein kinase BMX, Tyrosine-protein kinase Blk, Aurora kinase A, Aurora kinase B, Aurora kinase C, Cyclin-dependent kinase 3, Tyrosine-protein kinase ZAP-70, Vascular endothelial growth factor receptor 1, Vascular endothelial growth factor receptor 2, AP2-associated protein kinase 1, Activated CDC42 kinase 1, Muscarinic acetylcholine receptor M4, Muscarinic acetylcholine receptor M2, Tyrosine-protein kinase ABL2, Tyrosine-protein kinase ABL1, RAC-gamma serine/threonine-protein kinase, Muscarinic acetylcholine receptor M1, ALK tyrosine kinase receptor, RAC-beta serine/threonine-protein kinase, RAC-alpha serine/threonine-protein kinase, 5'-AMP-activated protein kinase catalytic subunit alpha-1, 5'-AMP-activated protein kinase catalytic subunit alpha-2, Serine/threonine-protein kinase Chk1, Serine/threonine-protein kinase Chk2, Serine/threonine-protein kinase 32A, Tyrosine-protein kinase receptor UFO, Serine/threonine-protein kinase ULK1, Serine/threonine-protein kinase ULK2, Serine/threonine-protein kinase ULK3, Dual specificity protein kinase CLK1, Dual specificity protein kinase CLK2, Dual specificity protein kinase CLK4, Glycogen synthase kinase-3 beta, Glycogen synthase kinase-3 alpha, Tyrosine-protein kinase HCK, Mast/stem cell growth factor receptor Kit, Calcium/calmodulin-dependent protein kinase kinase 1, G protein-coupled receptor kinase 5, Insulin receptor-related protein, Insulin receptor, NUAK family SNF1-like kinase 2, Serine/threonine-protein kinase PAK 4, Serine/threonine-protein kinase PAK 6, PAS domain-containing serine/threonine-protein kinase, Serine/threonine-protein kinase PAK 1, Serine/threonine-protein kinase PAK 2, Serine/threonine-protein kinase PAK 3, NUAK family SNF1-like kinase 1, Myosin light chain kinase 2, skeletal/cardiac muscle, BDNF/NT-3 growth factors receptor, High affinity nerve growth factor receptor, NT-3 growth factor receptor, NADPH oxidase 4, Calcium/calmodulin-dependent protein kinase type 1, Calcium/calmodulin-dependent protein kinase type II subunit alpha, Calcium/calmodulin-dependent protein kinase type II subunit delta, Calcium/calmodulin-dependent protein kinase type II subunit gamma, Tyrosine-protein kinase JAK2, cAMP-dependent protein kinase catalytic subunit alpha, Protein kinase C gamma type, Protein kinase C alpha type, Ribosomal protein S6 kinase beta-2, Mitogen-activated protein kinase 1, Mitogen-activated protein kinase 14, Protein kinase C theta type, Ribosomal protein S6 kinase alpha-3, Ribosomal protein S6 kinase alpha-4, Serine/threonine-protein kinase D3, Mitogen-activated protein kinase kinase kinase 9, Serine/threonine-protein kinase MARK1, Serine/threonine-protein kinase MRCK beta, Serine/threonine-protein kinase MRCK gamma, Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 5, Myosin-IIIb, Muscle, skeletal receptor tyrosine-protein kinase, Myosin light chain kinase, smooth muscle, 3-phosphoinositide-dependent protein kinase 1
  4. 昂丹司琼盐酸盐 二水合物
    CAS: 103639-04-9 分子式: C18H19N3O·HCl·2H2O 分子量: 365.85
    有现货 货号: O129679
    查看产品
    价格与包装
    技术标识符
    IUPAC名称
    9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one;dihydrate;hydrochloride
    SMILES
    CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.O.O.Cl
    InChIKey
    VRSLTNZJOUZKLX-UHFFFAOYSA-N
    InChI
    1S/C18H19N3O.ClH.2H2O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2;;;/h3-6,9-10,13H,7-8,11H2,1-2H3;1H;2*1H2
  5. 恩丹西酮
    CAS: 99614-02-5 EC号: 619-449-4 分子式: C18H19N3O 分子量: 293.36
    Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。 ≥99%
    有现货 货号: O129694
    查看产品
    价格与包装
    技术标识符
    IUPAC名称
    9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one
    SMILES
    CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
    InChIKey
    FELGMEQIXOGIFQ-UHFFFAOYSA-N
    InChI
    1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3
    关联靶标
    Solute carrier family 22 member 2, Multidrug and toxin extrusion protein 2, Multidrug and toxin extrusion protein 1, 5-hydroxytryptamine receptor 3B, 5-hydroxytryptamine receptor 3A, Potassium voltage-gated channel subfamily H member 2
  6. 1,3,5-三[4-(9-咔唑基)苯基]苯
    CAS: 160780-82-5 化合物 CID: 18991218 分子式: C60H39N3 分子量: 801.99
    有现货 货号: T161594
    查看产品
    价格与包装
    技术标识符
    IUPAC名称
    9-[4-[3,5-bis(4-carbazol-9-ylphenyl)phenyl]phenyl]carbazole
    SMILES
    C1=CC=C2C(=C1)C3=CC=CC=C3N2C4=CC=C(C=C4)C5=CC(=CC(=C5)C6=CC=C(C=C6)N7C8=CC=CC=C8C9=CC=CC=C97)C1=CC=C(C=C1)N1C2=CC=CC=C2C2=CC=CC=C21
    InChIKey
    XCICDYGIJBPNPC-UHFFFAOYSA-N
    InChI
    1S/C60H39N3/c1-7-19-55-49(13-1)50-14-2-8-20-56(50)61(55)46-31-25-40(26-32-46)43-37-44(41-27-33-47(34-28-41)62-57-21-9-3-15-51(57)52-16-4-10-22-58(52)62)39-45(38-43)42-29-35-48(36-30-42)63-59-23-11-5-1显示更多
  7. 1,3,5-三(9H-咔唑-9-基)苯
    CAS: 148044-07-9 化合物 CID: 22218951 分子式: C42H27N3 分子量: 573.68
    有现货 货号: T123337
    查看产品
    价格与包装
    技术标识符
    IUPAC名称
    9-[3,5-di(carbazol-9-yl)phenyl]carbazole
    SMILES
    C1=CC=C2C(=C1)C3=CC=CC=C3N2C4=CC(=CC(=C4)N5C6=CC=CC=C6C7=CC=CC=C75)N8C9=CC=CC=C9C1=CC=CC=C18
    InChIKey
    DVNOWTJCOPZGQA-UHFFFAOYSA-N
    InChI
    1S/C42H27N3/c1-7-19-37-31(13-1)32-14-2-8-20-38(32)43(37)28-25-29(44-39-21-9-3-15-33(39)34-16-4-10-22-40(34)44)27-30(26-28)45-41-23-11-5-17-35(41)36-18-6-12-24-42(36)45/h1-27H
每页
🚚
快速发货 现货产品当日发货
📋
技术详情 每个产品页均提供质量和规格信息
📦
多种规格 多种包装规格和价格可选
🔬
仅供科研 产品仅供研发使用